Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-19 ERVK-25 ERVK-24 ERVK-8	6.02e-09	37	222	8	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-19 ERVK-25 ERVK-24 ERVK-8	7.55e-09	38	222	8	GO:0070001
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-8	2.09e-04	11	222	3	GO:0004523
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH14 DNAH6 DNAH10 RAB11FIP3	2.47e-04	28	222	4	GO:0051959
GeneOntologyMolecularFunction	nuclear export signal receptor activity	XPO5 RANBP17 CSE1L	2.77e-04	12	222	3	GO:0005049
GeneOntologyMolecularFunction	nucleocytoplasmic carrier activity	XPO5 RANBP17 CSE1L TNPO3	4.19e-04	32	222	4	GO:0140142
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF21B ATP8B4 ATP8A2 PEX6 AK9 ATP8A1 ATP2C2 TOR1B DNAH6 RAD54L DNAH10 ABCC5 FANCM CCT8	4.42e-04	441	222	14	GO:0016887
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-8	4.51e-04	14	222	3	GO:0003964
Domain	ARM-type_fold	TRPC4AP TSC2 FOCAD PSME4 AP1B1 XPO5 MROH7 ULK4 RIC8A MMS19 GCN1 UNC79 ARMC8 COPB1 RTTN HEATR5A VIRMA RSPRY1 RANBP17 RIC8B HEATR6 CSE1L MTOR LTA4H PRKDC CFAP69 TNPO3	3.20e-15	339	217	27	IPR016024
Domain	ARM-like	TSC2 PSME4 AP1B1 XPO5 MROH7 ULK4 RIC8A MMS19 GCN1 ARMC8 COPB1 RTTN HEATR5A RSPRY1 RANBP17 RIC8B HEATR6 CSE1L MTOR CEP70 PRKDC CFAP69 TNPO3	9.79e-14	270	217	23	IPR011989
Domain	-	TSC2 PSME4 AP1B1 XPO5 MROH7 ULK4 RIC8A MMS19 GCN1 ARMC8 COPB1 RTTN HEATR5A RANBP17 RIC8B HEATR6 CSE1L MTOR PRKDC CFAP69 TNPO3	1.58e-13	222	217	21	1.25.10.10
Domain	HEAT_REPEAT	PSME4 MROH7 ULK4 MMS19 GCN1 ARMC8 HEATR5A HEATR6 MTOR PRKDC	7.87e-09	70	217	10	PS50077
Domain	NACHT	CIITA NLRP8 NLRP9 NLRP14 NLRP4	5.74e-06	23	217	5	PS50837
Domain	NACHT_NTPase	CIITA NLRP8 NLRP9 NLRP14 NLRP4	5.74e-06	23	217	5	IPR007111
Domain	Ank_2	ACAP1 ANKRD39 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB8 ANKRD28 ANKRD52 ANKRD20A1 FEM1B SNCAIP KANK3	8.42e-06	215	217	12	PF12796
Domain	Ank	ACAP1 ANKRD39 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB8 ANKRD28 ANKRD52 ANKRD20A1 FEM1B SNCAIP KANK3	1.52e-05	228	217	12	PF00023
Domain	-	ACAP1 ANKRD39 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB8 ANKRD28 ANKRD52 ANKRD20A1 FEM1B SNCAIP KANK3	3.49e-05	248	217	12	1.25.40.20
Domain	ANK	ACAP1 ANKRD39 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB8 ANKRD28 ANKRD52 ANKRD20A1 FEM1B SNCAIP KANK3	3.92e-05	251	217	12	SM00248
Domain	LRR_6	FBXL7 CIITA NLRP8 NLRP9 NLRP14 NLRP4	4.14e-05	55	217	6	PF13516
Domain	ANK_REPEAT	ACAP1 ANKRD39 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB8 ANKRD28 ANKRD52 ANKRD20A1 FEM1B SNCAIP KANK3	4.24e-05	253	217	12	PS50088
Domain	Ankyrin_rpt-contain_dom	ACAP1 ANKRD39 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB8 ANKRD28 ANKRD52 ANKRD20A1 FEM1B SNCAIP KANK3	4.40e-05	254	217	12	IPR020683
Domain	ANK_REP_REGION	ACAP1 ANKRD39 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB8 ANKRD28 ANKRD52 ANKRD20A1 FEM1B SNCAIP KANK3	4.40e-05	254	217	12	PS50297
Domain	Ankyrin_rpt	ACAP1 ANKRD39 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB8 ANKRD28 ANKRD52 ANKRD20A1 FEM1B SNCAIP KANK3	5.94e-05	262	217	12	IPR002110
Domain	PIPLC_X_DOMAIN	ACAP1 PLCXD2 PLCH1 PLCE1	5.99e-05	19	217	4	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	ACAP1 PLCXD2 PLCH1 PLCE1	5.99e-05	19	217	4	IPR000909
Domain	DAPIN	NLRP8 NLRP9 NLRP14 NLRP4	1.10e-04	22	217	4	PS50824
Domain	PYRIN	NLRP8 NLRP9 NLRP14 NLRP4	1.10e-04	22	217	4	SM01289
Domain	PYRIN	NLRP8 NLRP9 NLRP14 NLRP4	1.10e-04	22	217	4	PF02758
Domain	DAPIN	NLRP8 NLRP9 NLRP14 NLRP4	1.10e-04	22	217	4	IPR004020
Domain	Ribosomal_L44e	RPL36AL RPL36A	1.34e-04	2	217	2	IPR000552
Domain	Ribosomal_L44e	RPL36AL RPL36A	1.34e-04	2	217	2	PD002841
Domain	Gua_nucleotide_exch_fac_Ric8	RIC8A RIC8B	1.34e-04	2	217	2	IPR019318
Domain	RIBOSOMAL_L44E	RPL36AL RPL36A	1.34e-04	2	217	2	PS01172
Domain	Ribosomal_L44	RPL36AL RPL36A	1.34e-04	2	217	2	PF00935
Domain	Synembryn	RIC8A RIC8B	1.34e-04	2	217	2	IPR008376
Domain	Ric8	RIC8A RIC8B	1.34e-04	2	217	2	PF10165
Domain	-	RPL36AL RPL36A	1.34e-04	2	217	2	3.10.450.80
Domain	-	RNF181 MKRN2 PEX10 FYCO1 TRIM66 ZFYVE9 ZFYVE21 TRIM48 RNF26 SH3RF1 TRIM73 RNF212 ZMIZ1 RSPRY1 VPS41	2.55e-04	449	217	15	3.30.40.10
Domain	Znf_RING/FYVE/PHD	RNF181 MKRN2 PEX10 FYCO1 TRIM66 ZFYVE9 ZFYVE21 TRIM48 RNF26 SH3RF1 TRIM73 RNF212 ZMIZ1 RSPRY1 VPS41	3.22e-04	459	217	15	IPR013083
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DNAH6 DNAH10	5.12e-04	14	217	3	IPR024317
Domain	Dynein_HC_stalk	DNAH14 DNAH6 DNAH10	5.12e-04	14	217	3	IPR024743
Domain	P_typ_ATPase_c	ATP8B4 ATP8A2 ATP8A1	5.12e-04	14	217	3	IPR032630
Domain	P-type_ATPase_N	ATP8B4 ATP8A2 ATP8A1	5.12e-04	14	217	3	IPR032631
Domain	P-type_ATPase_IV	ATP8B4 ATP8A2 ATP8A1	5.12e-04	14	217	3	IPR006539
Domain	MT	DNAH14 DNAH6 DNAH10	5.12e-04	14	217	3	PF12777
Domain	AAA_8	DNAH14 DNAH6 DNAH10	5.12e-04	14	217	3	PF12780
Domain	PhoLip_ATPase_C	ATP8B4 ATP8A2 ATP8A1	5.12e-04	14	217	3	PF16212
Domain	PhoLip_ATPase_N	ATP8B4 ATP8A2 ATP8A1	5.12e-04	14	217	3	PF16209
Domain	DHC_fam	DNAH14 DNAH6 DNAH10	6.35e-04	15	217	3	IPR026983
Domain	Dynein_heavy	DNAH14 DNAH6 DNAH10	6.35e-04	15	217	3	PF03028
Domain	Dynein_heavy_dom	DNAH14 DNAH6 DNAH10	6.35e-04	15	217	3	IPR004273
Domain	ATPase_P-typ_cyto_domN	ATP8B4 ATP8A2 ATP8A1 ATP2C2	7.00e-04	35	217	4	IPR023299
Domain	-	MALT1 NLRP8 CASP10 NLRP9 NLRP14 NLRP4	7.55e-04	93	217	6	1.10.533.10
Domain	VWF_type-D	VWDE BMPER MUC5AC	7.75e-04	16	217	3	IPR001846
Domain	IBN_N	XPO5 RANBP17 CSE1L	7.75e-04	16	217	3	SM00913
Domain	VWFD	VWDE BMPER MUC5AC	7.75e-04	16	217	3	PS51233
Domain	VWD	VWDE BMPER MUC5AC	7.75e-04	16	217	3	SM00216
Domain	VWD	VWDE BMPER MUC5AC	7.75e-04	16	217	3	PF00094
Domain	ATPase_P-typ_P_site	ATP8B4 ATP8A2 ATP8A1 ATP2C2	7.80e-04	36	217	4	IPR018303
Domain	P_typ_ATPase	ATP8B4 ATP8A2 ATP8A1 ATP2C2	7.80e-04	36	217	4	IPR001757
Domain	ATPASE_E1_E2	ATP8B4 ATP8A2 ATP8A1 ATP2C2	7.80e-04	36	217	4	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP8B4 ATP8A2 ATP8A1 ATP2C2	8.67e-04	37	217	4	IPR008250
Domain	E1-E2_ATPase	ATP8B4 ATP8A2 ATP8A1 ATP2C2	8.67e-04	37	217	4	PF00122
Domain	Importin-beta_N	XPO5 RANBP17 CSE1L	9.33e-04	17	217	3	IPR001494
Domain	SOCS_box	ASB8 RAB40AL RAB40B RAB40A	9.60e-04	38	217	4	PF07525
Domain	DEATH-like_dom	MALT1 NLRP8 CASP10 NLRP9 NLRP14 NLRP4	1.05e-03	99	217	6	IPR011029
Domain	SOCS_box	ASB8 RAB40AL RAB40B RAB40A	1.06e-03	39	217	4	SM00969
Domain	SOCS_box	ASB8 RAB40AL RAB40B RAB40A	1.06e-03	39	217	4	IPR001496
Domain	SOCS	ASB8 RAB40AL RAB40B RAB40A	1.06e-03	39	217	4	PS50225
Domain	PI-PLC-X	PLCXD2 PLCH1 PLCE1	1.11e-03	18	217	3	PF00388
Domain	PLCXc	PLCXD2 PLCH1 PLCE1	1.11e-03	18	217	3	SM00148
Domain	FATC	MTOR PRKDC	1.31e-03	5	217	2	PF02260
Domain	SOCS	RAB40AL RAB40B RAB40A	1.52e-03	20	217	3	SM00253
Domain	Xpo1	XPO5 TNPO3	1.95e-03	6	217	2	PF08389
Domain	FAT	MTOR PRKDC	1.95e-03	6	217	2	PS51189
Domain	FATC	MTOR PRKDC	1.95e-03	6	217	2	PS51190
Domain	FAT	MTOR PRKDC	1.95e-03	6	217	2	PF02259
Domain	PIK-rel_kinase_FAT	MTOR PRKDC	1.95e-03	6	217	2	IPR003151
Domain	FATC_dom	MTOR PRKDC	1.95e-03	6	217	2	IPR003152
Domain	PIK_FAT	MTOR PRKDC	1.95e-03	6	217	2	IPR014009
Domain	Exportin-1/Importin-b-like	XPO5 TNPO3	1.95e-03	6	217	2	IPR013598
Domain	FATC	MTOR PRKDC	1.95e-03	6	217	2	SM01343
Domain	P-loop_NTPase	KIF21B PEX6 AK9 DNAH14 CIITA RAB40AL TOR1B RAB40B DNAH6 RAD54L NLRP8 DNAH10 ABCC5 IQCN RAB40A FANCM NLRP9 NLRP14 HNRNPUL2 NLRP4	2.16e-03	848	217	20	IPR027417
Domain	ZF_RING_1	RNF181 MKRN2 PEX10 TRIM48 RNF26 SH3RF1 TRIM73 RNF212 RSPRY1 VPS41	2.21e-03	291	217	10	PS00518
Domain	ZF_RING_2	RNF181 MKRN2 PEX10 TRIM48 RNF26 SH3RF1 TRIM73 RNF212 RSPRY1 VPS41	2.63e-03	298	217	10	PS50089
Domain	TB	FBN2 LTBP3	2.72e-03	7	217	2	PF00683
Domain	-	PLCXD2 PLCH1 PLCE1	2.95e-03	25	217	3	3.20.20.190
Domain	PLC-like_Pdiesterase_TIM-brl	PLCXD2 PLCH1 PLCE1	2.95e-03	25	217	3	IPR017946
Domain	RING	RNF181 MKRN2 PEX10 TRIM48 RNF26 SH3RF1 TRIM73 RNF212 RSPRY1 VPS41	3.10e-03	305	217	10	SM00184
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PEX6 TSC2 FYCO1 ITGB4 TBC1D9 FOCAD PSME4 BANP MAP3K11 ULK4 CACNA1H RIC8A HERC1 GCN1 MYRF ALOX5 SH3RF1 GRK6 RTTN RELB CEP192 FAAP100 LATS2 DOK4 MTOR KANK3 DIP2C LTBP3 PRKDC ARHGEF2 TNPO3 RAB11FIP3	1.90e-12	1105	227	32	35748872
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-21 ERVK-9 ERVK-19 ERVK-8	8.65e-09	12	227	5	14557543
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-21 ERVK-19	8.79e-09	5	227	4	12629516
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	FBXL7 NRXN2 XPO5 MLC1 RAB3GAP2 ZBTB40 ANKRD28 GCN1 DIS3 DIP2C APPL1 AKAP11	3.44e-08	225	227	12	12168954
Pubmed	Expression of testicular germ cell genes identified by differential display analysis.	ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	1.21e-07	8	227	4	12634303
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-19 ERVK-25 ERVK-24 ERVK-8	2.00e-07	94	227	8	21542922
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	TRIP6 MKRN2 FYCO1 TBC1D9 XPO5 HERC1 GCN1 COPB1 COX5B DIS3 CSE1L HNRNPUL2	4.44e-07	285	227	12	32838362
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF536 TSPOAP1 FOCAD XPO5 MLC1 PCDH19 RAB3GAP2 CACNA1H HEATR5A CEP192 VIRMA EPG5 FEM1B PLCE1	5.58e-07	407	227	14	12693553
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	FBXW10B ATP8B4 DEPDC4 TSPOAP1 TBC1D9 FBN2 AP1B1 ZBTB40 ULK4 ERVK-25 ABCC5 ZMIZ1 RIC8B IRAG2 AKAP11 ARHGEF2	8.35e-07	552	227	16	10737800
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	ITGB4 XPO5 MROH7 MMS19 GCN1 NBAS HEATR6 MTOR PRKDC ARHGEF2	9.60e-07	202	227	10	33005030
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-24	1.09e-06	4	227	3	10469592
Pubmed	Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A.	PHGDH XPO5 GCN1 CSE1L CCT8 AKAP11 PRKDC	1.15e-06	82	227	7	30274258
Pubmed	Large-scale concatenation cDNA sequencing.	TRPC4AP MMADHC TBC1D9 MALT1 ATP8A1 CACNA1H MMS19 HERC1 DOK1 CACNA1C CAV1 ZMIZ1 GRM5 DIS3 KANK3 RAB11FIP3	1.21e-06	568	227	16	9110174
Pubmed	A "double adaptor" method for improved shotgun library construction.	TRPC4AP MMADHC TBC1D9 MALT1 ATP8A1 CACNA1H MMS19 HERC1 DOK1 CACNA1C CAV1 ZMIZ1 GRM5 DIS3 KANK3 RAB11FIP3	1.39e-06	574	227	16	8619474
Pubmed	The genetics of NOD-like receptors in Crohn's disease.	NLRP8 NLRP9 NLRP14 NLRP4	1.68e-06	14	227	4	20403135
Pubmed	NALPs: a novel protein family involved in inflammation.	NLRP8 NLRP9 NLRP14 NLRP4	1.68e-06	14	227	4	12563287
Pubmed	Rab40b and Tks5 interact at invadopodia during metastasis.	RAB40AL RAB40B RAB40A	2.72e-06	5	227	3	27909076
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	PHGDH XPO5 MMS19 GCN1 ARMC8 CSE1L MTOR PRKDC TNPO3	3.57e-06	183	227	9	23956138
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	KIF21B CACNA1H DNAH6 DNAH10 RTTN ZFC3H1 IRAG2 CCT8 MUC5AC	4.25e-06	187	227	9	26460568
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-21 ERVK-9 ERVK-25 ERVK-24	5.03e-06	18	227	4	18664271
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ATP8B4 TBC1D9 TRIM66 PRMT7 SH3RF1 DGKD ZFC3H1 FANCM RSPRY1 USF3 DIP2C CCT8 APPL1 PLCH1	5.19e-06	493	227	14	15368895
Pubmed	Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.	ERVK-6 ERVK-9 ERVK-19	5.41e-06	6	227	3	15063128
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	PDXDC1 RPL36AL ACO1 FYCO1 PHGDH AP1B1 GCN1 UNC79 COPB1 IQCN EPG5 NBAS PTPA CSE1L CCT8 LTA4H PRKDC PCCB	6.86e-06	807	227	18	30575818
Pubmed	Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network.	PHGDH XPO5 MMS19 GCN1 SLC25A15 CCT8 TNPO3	8.79e-06	111	227	7	32683582
Pubmed	Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4-ATPases.	ATP8B4 ATP8A2 ATP8A1	9.42e-06	7	227	3	20947505
Pubmed	Defining the membrane proteome of NK cells.	ABHD15 ACAP1 DHRS13 FYCO1 MFGE8 ATP8A1 MAP3K11 MMS19 GCN1 HNRNPLL DPP4 COPB1 GRK6 DIS3 NBAS SLC44A1 CSE1L HNRNPUL2 MTOR IRAG2 PRKDC MCTP2	9.49e-06	1168	227	22	19946888
Pubmed	A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.	PHGDH XPO5 GCN1 CAV1 CSE1L PRKDC ARHGEF2	1.31e-05	118	227	7	27377895
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	TRIP6 ZFYVE9 ANKRD28 ANKRD52 CEP192 APPL1 AKAP11	1.91e-05	125	227	7	29467281
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	PDXDC1 MKRN2 PHGDH AP1B1 XPO5 RIC8A GCN1 COPB1 DIS3 CSE1L MTOR CCT8 APPL1 PRKDC TNPO3	2.23e-05	638	227	15	33239621
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	ACO1 FYCO1 PSME4 XPO5 RIC8A MMS19 GCN1 DPP4 REXO5 PRAMEF22 CSE1L CCT8 PRKDC MUC5AC	2.33e-05	564	227	14	21565611
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	PDXDC1 TRPC4AP TRIP6 FBN2 AP1B1 XPO5 ANKRD28 GCN1 ANKRD52 HNRNPLL ARMC8 FAAP100 DIS3 CSE1L HNRNPUL2 MTOR CCT8 PRKDC TNPO3	2.46e-05	974	227	19	28675297
Pubmed	Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.	CYP2C18 ORC3 ITGB4 NLRP8 CASP10 NLRP14 PRKDC NLRP4	2.49e-05	179	227	8	19074885
Pubmed	Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan.	PDXDC1 FYCO1 MALT1 PSME4 WFS1 HEATR6 MTOR AKAP11	2.92e-05	183	227	8	31932471
Pubmed	Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins.	ERVK-6 ERVK-21 ERVK-19	3.18e-05	10	227	3	12970426
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	TSC2 GCN1 WEE1 VIRMA CSE1L MTOR PRKDC ARHGEF2	3.82e-05	190	227	8	15161933
Pubmed	UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.	GCN1 DIS3 MTOR PRKDC	4.24e-05	30	227	4	32867711
Pubmed	Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.	MTOR PRKDC	4.24e-05	2	227	2	27235137
Pubmed	MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.	CIITA PRKDC	4.24e-05	2	227	2	16081800
Pubmed	Transcellular biosynthesis of leukotriene B4 orchestrates neutrophil swarming to fungi.	ALOX5 LTA4H	4.24e-05	2	227	2	36267914
Pubmed	Exploring the conformational dynamics and key amino acids in the CD26-caveolin-1 interaction and potential therapeutic interventions.	DPP4 CAV1	4.24e-05	2	227	2	39259075
Pubmed	DNA-dependent protein kinase is a context dependent regulator of Lmx1a and midbrain specification.	LMX1A PRKDC	4.24e-05	2	227	2	24194952
Pubmed	Loss of TSC2 confers resistance to ceramide and nutrient deprivation.	TSC2 MTOR	4.24e-05	2	227	2	23604129
Pubmed	Amino acids regulate mTOR pathway and milk protein synthesis in a mouse mammary epithelial cell line is partly mediated by T1R1/T1R3.	MTOR TAS1R1	4.24e-05	2	227	2	27539583
Pubmed	Identification of predicted human outer dynein arm genes: candidates for primary ciliary dyskinesia genes.	DNAH6 DNAH10	4.24e-05	2	227	2	15937072
Pubmed	DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer.	MTOR PRKDC	4.24e-05	2	227	2	32209447
Pubmed	CTG repeat instability and size variation timing in DNA repair-deficient mice.	RAD54L PRKDC	4.24e-05	2	227	2	12727892
Pubmed	mTORC2 is required for proliferation and survival of TSC2-null cells.	TSC2 MTOR	4.24e-05	2	227	2	21482669
Pubmed	CACNA1H downregulation induces skeletal muscle atrophy involving endoplasmic reticulum stress activation and autophagy flux blockade.	CACNA1H CACNA1C	4.24e-05	2	227	2	32332705
Pubmed	Inter-tissue coexpression network analysis reveals DPP4 as an important gene in heart to blood communication.	FOCAD DPP4	4.24e-05	2	227	2	26856537
Pubmed	Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress.	TSC2 MTOR	4.24e-05	2	227	2	23699409
Pubmed	Promotion of autophagy and inhibition of apoptosis by low concentrations of cadmium in vascular endothelial cells.	ITGB4 CAV1	4.24e-05	2	227	2	19061949
Pubmed	TSC2 regulates VEGF through mTOR-dependent and -independent pathways.	TSC2 MTOR	4.24e-05	2	227	2	12957289
Pubmed	Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis.	TSC2 MTOR	4.24e-05	2	227	2	24591652
Pubmed	Role of mammalian Rad54 in telomere length maintenance.	RAD54L PRKDC	4.24e-05	2	227	2	12897131
Pubmed	mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity.	TSC2 MTOR	4.24e-05	2	227	2	34667149
Pubmed	Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder.	SLC25A2 SLC25A15	4.24e-05	2	227	2	12948741
Pubmed	Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.	RET MTOR	4.24e-05	2	227	2	23828865
Pubmed	Development of hypomelanotic macules is associated with constitutive activated mTORC1 in tuberous sclerosis complex.	TSC2 MTOR	4.24e-05	2	227	2	28336152
Pubmed	Structural basis for the specific recognition of RET by the Dok1 phosphotyrosine binding domain.	DOK1 RET	4.24e-05	2	227	2	14607833
Pubmed	Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo.	ALOX5 LTA4H	4.24e-05	2	227	2	12021253
Pubmed	Decreased rates of cerebral protein synthesis measured in vivo in a mouse model of Tuberous Sclerosis Complex: unexpected consequences of reduced tuberin.	TSC2 MTOR	4.24e-05	2	227	2	29364507
Pubmed	Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.	TSC2 MTOR	4.24e-05	2	227	2	22287548
Pubmed	Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.	CACNA1H CACNA1C	4.24e-05	2	227	2	23686856
Pubmed	Association of the α(2)δ(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes.	CACNA1H CACNA2D1	4.24e-05	2	227	2	21638318
Pubmed	Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.	TSC2 MTOR	4.24e-05	2	227	2	25972538
Pubmed	Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.	ERVK-6 ERVK-19	4.24e-05	2	227	2	9060628
Pubmed	Ca2+ influx through T- and L-type Ca2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes.	CACNA1H CACNA1C	4.24e-05	2	227	2	18832749
Pubmed	Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.	ERVK-6 ERVK-19	4.24e-05	2	227	2	9460924
Pubmed	A role of the mammalian target of rapamycin (mTOR) in glutamate-induced down-regulation of tuberous sclerosis complex proteins 2 (TSC2).	TSC2 MTOR	4.24e-05	2	227	2	22492229
Pubmed	Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1.	TSC2 MTOR	4.24e-05	2	227	2	21886784
Pubmed	mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.	TSC2 MTOR	4.24e-05	2	227	2	27023784
Pubmed	5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines.	ALOX5 LTA4H	4.24e-05	2	227	2	19919819
Pubmed	Intrinsic flexibility of NLRP pyrin domains is a key factor in their conformational dynamics, fold stability, and dimerization.	NLRP14 NLRP4	4.24e-05	2	227	2	25403012
Pubmed	Subcellular receptor redistribution and enhanced microspike formation by a Ret receptor preferentially recruiting Dok.	DOK1 RET	4.24e-05	2	227	2	18353552
Pubmed	Substrate specificity of the two mitochondrial ornithine carriers can be swapped by single mutation in substrate binding site.	SLC25A2 SLC25A15	4.24e-05	2	227	2	22262851
Pubmed	Ric-8 proteins are molecular chaperones that direct nascent G protein α subunit membrane association.	RIC8A RIC8B	4.24e-05	2	227	2	22114146
Pubmed	The mitochondrial ornithine transporter. Bacterial expression, reconstitution, functional characterization, and tissue distribution of two human isoforms.	SLC25A2 SLC25A15	4.24e-05	2	227	2	12807890
Pubmed	Pancreatic β-cell failure mediated by mTORC1 hyperactivity and autophagic impairment.	TSC2 MTOR	4.24e-05	2	227	2	24740570
Pubmed	Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation.	DOK1 RET DOK4	4.36e-05	11	227	3	11470823
Pubmed	NODs: intracellular proteins involved in inflammation and apoptosis.	NLRP8 NLRP9 NLRP14	5.78e-05	12	227	3	12766759
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF21B TRAF3IP1 TSC2 FYCO1 CCDC177 AP1B1 KCNJ4 ANKRD28 UNC79 ARMC8 CACNA2D1 GRM5 VIRMA HNRNPUL2 MTOR CCT8 APPL1 ARHGEF2	6.96e-05	963	227	18	28671696
Pubmed	The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.	TRIP6 MKRN2 PHGDH RAB3GAP2 RIC8A COX5B VIRMA CSE1L MTOR SLC25A15 TNPO3	7.17e-05	400	227	11	35013556
Pubmed	Differential expression of putative transbilayer amphipath transporters.	ATP8B4 ATP8A2 ATP8A1	7.48e-05	13	227	3	11015572
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	ACO1 PEX6 PEX10 NDUFS8 FOCAD XPO5 TOR1B HERC1 MYRF WDR72 WFS1 CAV1 DIS3 PTPA SLC25A2 VPS41 PRKDC ARHGEF2 PCCB	7.68e-05	1061	227	19	33845483
Pubmed	Protein interaction profiling of the p97 adaptor UBXD1 points to a role for the complex in modulating ERGIC-53 trafficking.	RAB3GAP2 COPB1 CCT8 PRKDC	7.89e-05	35	227	4	22337587
Pubmed	Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.	PSME4 XPO5 MMS19 GCN1 CSE1L CCT8 PRKDC ARHGEF2	7.98e-05	211	227	8	17314511
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	ITFG1 AP1B1 XPO5 MMS19 HERC1 MYRF WDR72 GRK6 RTTN ABCC5 DGKD CEP192 FEM1B SLC44A1 HNRNPUL2	8.59e-05	719	227	15	35337019
Pubmed	RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes.	PHGDH NDUFS8 FOCAD XPO5 GCN1 COPB1 CSE1L CCT8 PRKDC PCCB	9.71e-05	344	227	10	36282215
Pubmed	Stasimon/Tmem41b localizes to mitochondria-associated ER membranes and is essential for mouse embryonic development.	PHGDH XPO5 GCN1 COPB1 CCT8 PRKDC	1.02e-04	113	227	6	30352685
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	FBN2 EPG5 LTBP3 MUC5AC ZNF292	1.04e-04	71	227	5	33541421
Pubmed	Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach.	PHGDH XPO5 GCN1 CSE1L PRKDC	1.19e-04	73	227	5	23464991
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRPC4AP DNAH14 ITFG1 MALT1 BANP CACNA1H RAB40B UBE2E3 CACNA1C CEP192 IQCN ZMIZ1 RANBP17 PACS1 RIC8B USF3 LATS2 TBCK VPS41 DIP2C CFAP69 MCTP2 CPNE7	1.26e-04	1489	227	23	28611215
Pubmed	The mouse germ-cell-specific leucine-rich repeat protein NALP14: a member of the NACHT nucleoside triphosphatase family.	NLRP14 NLRP4	1.27e-04	3	227	2	15590904
Pubmed	Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner.	TSC2 MTOR	1.27e-04	3	227	2	17562867
Pubmed	Role of Dok1 in cell signaling mediated by RET tyrosine kinase.	DOK1 RET	1.27e-04	3	227	2	12087092
Pubmed	Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation.	ALOX5 LTA4H	1.27e-04	3	227	2	19416808
Pubmed	Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.	TSC2 MTOR	1.27e-04	3	227	2	15624760
Pubmed	Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population.	CACNA1H CACNA1C	1.27e-04	3	227	2	26216687
Pubmed	Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor-mediated radiation resistance.	PTPA PRKDC	1.27e-04	3	227	2	22923485
Pubmed	Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain.	TSC2 MTOR	1.27e-04	3	227	2	17018601
Interaction	OPALIN interactions	TSC2 XPO5 GCN1 WFS1 RTTN HEATR6 CSE1L MTOR SLC25A15 PRKDC TNPO3 CPNE7	3.38e-06	209	220	12	int:OPALIN
Interaction	TOP3B interactions	MKRN2 PEX6 TSC2 FYCO1 ITGB4 PHGDH TBC1D9 FOCAD PSME4 XPO5 BANP MAP3K11 ULK4 CACNA1H RIC8A MMS19 HERC1 GCN1 MYRF ALOX5 SH3RF1 GRK6 RTTN RELB CEP192 FAAP100 LATS2 DOK4 MTOR KANK3 DIP2C LTBP3 PRKDC ARHGEF2 TNPO3 RAB11FIP3	4.00e-06	1470	220	36	int:TOP3B
Interaction	ATP8A1 interactions	ATP8A2 ATP8A1 AP1B1 COPB1 VIRMA	1.69e-05	30	220	5	int:ATP8A1
GeneFamily	Ankyrin repeat domain containing	ACAP1 ANKRD39 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB8 ANKRD28 ANKRD52 ANKRD20A1 FEM1B SNCAIP KANK3	5.09e-07	242	143	12	403
GeneFamily	NLR family	CIITA NLRP8 NLRP9 NLRP14 NLRP4	1.35e-06	25	143	5	666
GeneFamily	Dyneins, axonemal	DNAH14 DNAH6 DNAH10 DNAI2	8.24e-06	17	143	4	536
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	NLRP8 NLRP9 NLRP14 NLRP4	4.17e-05	25	143	4	994
GeneFamily	ATPase phospholipid transporting	ATP8B4 ATP8A2 ATP8A1	2.06e-04	15	143	3	1210
GeneFamily	Ring finger proteins	RNF181 MKRN2 PEX10 TRIM48 RNF26 SH3RF1 TRIM73 RNF212 RSPRY1	3.45e-04	275	143	9	58
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	TRPC4AP TSC2 ANKRD28 SPOCD1 CEP192 GRM5 AKAP11	5.98e-04	181	143	7	694
GeneFamily	Protein phosphatase 6 regulatory subunits	ANKRD28 ANKRD52	9.13e-04	6	143	2	699
GeneFamily	Calcium voltage-gated channel subunits	CACNA1H CACNA1C CACNA2D1	1.10e-03	26	143	3	253
GeneFamily	Exportins	XPO5 CSE1L	1.27e-03	7	143	2	547
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	FYCO1 ZFYVE9 ZFYVE21	1.85e-03	31	143	3	81
GeneFamily	Exosome complex	DIS3 EXOSC7	3.89e-03	12	143	2	817
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	ATP8B4 ATP8A1 CIITA ZBTB40 TRIM73 NBAS TBCK PRKDC MCTP2 ZNF292	3.96e-08	191	219	10	9454f642c3621370fa23640b631301346b300950
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABHD15 APOBEC2 ULK4 HERC1 CACNA1C CACNA2D1 WFS1 HEATR6 AKAP11	2.57e-07	178	219	9	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH14 ATP8A1 ATP2C2 MYRF SH3RF1 RANBP17 CEP70 LTA4H PLCH1	2.96e-07	181	219	9	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	ATP8B4 ATP8A1 CIITA ZBTB40 TRIM73 NBAS PRKDC MCTP2 ZNF292	3.56e-07	185	219	9	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	ATP8B4 ATP8A1 CIITA ZBTB40 TRIM73 NBAS PRKDC MCTP2 ZNF292	3.73e-07	186	219	9	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH14 ATP8A1 ATP2C2 ANKRD28 RANBP17 CEP70 LTA4H PLCH1 MCTP2	3.73e-07	186	219	9	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 CCDC28A-AS1 DNAH6 DNAH10 GRM5 DNAI2 CFAP57 CFAP69	1.98e-06	169	219	8	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	AT2_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD20A2P ANKRD20A3P ITGB4 ANKRD20A4P CACNA1C PCDHGB2 RANBP17	3.94e-06	131	219	7	ff4e618bd944f852bbd34438f740187aca82460f
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	FBXL7 ATP2C2 UNC79 SH3RF1 RTTN DGKD PLCH1 MCTP2	4.36e-06	188	219	8	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	COPD-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	TSPOAP1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1 DPP4 PACS1	4.90e-06	191	219	8	3480e6d27dd4291765bbbb2acdb6a2e4f02c8085
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH14 ATP8A1 ATP2C2 MYRF RANBP17 CEP70 ARHGEF2 PLCH1	4.90e-06	191	219	8	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH14 ATP8A1 ATP2C2 MYRF SH3RF1 RANBP17 CEP70 PLCH1	5.29e-06	193	219	8	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRAF3IP1 AK9 ULK4 DNAH6 DNAH10 DNAI2 CFAP57 CFAP69	5.49e-06	194	219	8	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	Control-Neu_4\|Control / 5 Neutrophil clusters in COVID-19 patients	ATP8B4 ANKRD20A4P ARMC8 DNAH10 COPB1 CCNG1 CSE1L APPL1	5.92e-06	196	219	8	b8b7b54ca17a08fa775507bb22b1c7248ada8f40
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH14 ATP8A1 ATP2C2 SH3RF1 DGKD RANBP17 CEP70 PLCH1	6.62e-06	199	219	8	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	AK9 FAM221B ATP2C2 DNAH6 DNAH10 LMX1A DNAI2 CFAP57	6.86e-06	200	219	8	4992dbf0514d674017315dbd20d91dfec0c608e9
ToppCell	368C-Fibroblasts-Fibroblast-H-\|368C / Donor, Lineage, Cell class and subclass (all cells)	NRXN2 RAB40AL RNF26 MRGPRF BCDIN3D TAS1R1 DIP2C	1.05e-05	152	219	7	dbfb4d4de36ef9f5c7da1950baa915b12788685e
ToppCell	368C-Fibroblasts-Fibroblast-H\|368C / Donor, Lineage, Cell class and subclass (all cells)	NRXN2 RAB40AL RNF26 MRGPRF BCDIN3D TAS1R1 DIP2C	1.05e-05	152	219	7	9f3682da00fd627e80aa820ecc6f5fed23b9738a
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AK9 DNAH6 RAD54L PCDHGA3 RTTN CFAP69 PLCE1	1.29e-05	157	219	7	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATP8B4 PLCXD2 ZNF547 ZBTB40 PRMT7 RAB40A CPNE7	1.46e-05	160	219	7	50d4f867d021abcfeb49e6812bcfd5bb57466a31
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATP8B4 PLCXD2 ZNF547 ZBTB40 PRMT7 RAB40A CPNE7	1.46e-05	160	219	7	0f15f895f11dcabb73df79b26bfc4947f38435a7
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATP8B4 PLCXD2 ZNF547 ZBTB40 PRMT7 RAB40A CPNE7	1.46e-05	160	219	7	7d004bfe42707605b3851cb2319126acda4d4802
ToppCell	PND10-Endothelial-Endothelial_lymphatic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGB4 NRXN2 MROH7 SELENOP CPNE7 PLCE1 RAB11FIP3	1.71e-05	164	219	7	f13b8d9b7f42193f333d9a77571a1dde6bbb48d8
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGB4 NRXN2 MROH7 SELENOP CPNE7 PLCE1 RAB11FIP3	1.71e-05	164	219	7	4cfc9f92e49f86d3639e018b35b6a60dc62f494a
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGB4 NRXN2 MROH7 SELENOP CPNE7 PLCE1 RAB11FIP3	1.71e-05	164	219	7	7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGB4 NRXN2 MROH7 SELENOP CPNE7 PLCE1 RAB11FIP3	1.71e-05	164	219	7	5e5bd81414ea2d64f73cdef19a0a78c17bec8c18
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATP8A2 VWDE CACNA1H UNC79 CACNA2D1 RET SLC25A15	1.93e-05	167	219	7	c87ebfa8c3284ad33579190e148c95bcaf670d17
ToppCell	3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages\|Lung / Manually curated celltypes from each tissue	ATP8B4 AP1B1 CIITA SELENOP ABCC5 SNCAIP PLCH1	2.08e-05	169	219	7	241644823e6f949aaf4c671d4579721d7ef6b0e5
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACAP1 ATP8B4 MLC1 DPP4 RNF212 KANK3 MCTP2	2.08e-05	169	219	7	e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 ULK4 DNAH6 DNAH10 DNAI2 CFAP57 CFAP69	2.08e-05	169	219	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACAP1 ATP8B4 MLC1 DPP4 RNF212 KANK3 MCTP2	2.08e-05	169	219	7	d375a1df1ecc938f66bad92e54b8cda26ca9c472
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACAP1 ATP8B4 MLC1 DPP4 RNF212 KANK3 MCTP2	2.08e-05	169	219	7	58f805c0be507bd5fadc9ea3555032daabbc8ab8
ToppCell	mild_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	VWDE CCDC28A-AS1 CACNA1C SELENOP RANBP17 FAM124B CFAP69	2.16e-05	170	219	7	85c476e0bc496445e868a88849960598d97bdea2
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	PLCXD2 ITGB4 CACNA1H MYRF WFS1 CAV1 MUC5AC	2.33e-05	172	219	7	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PSME4 CIITA ANKRD28 PCDHGB2 RNF212 CASP10 RIC8B	2.42e-05	173	219	7	b335ca2a247156eba821943b2b9fc9922230b409
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABHD15 ULK4 HERC1 CACNA1C CACNA2D1 MTOR AKAP11	2.51e-05	174	219	7	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	IL20RB VWDE ATP8A1 HEATR5A RET DOK4 NALF2	2.80e-05	177	219	7	15a5c96ea840376e54933ebe7a8334a11d9ce411
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B MKRN2 NRXN2 ANKRD28 UNC79 USF3 CFAP69	3.01e-05	179	219	7	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLCXD2 APOBEC2 MMS19 MYRF SH3RF1 WFS1 CAV1	3.01e-05	179	219	7	d5e3e7f1cd8f683f39a7416f12af7e766dcbead8
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 ITGB4 ZBTB40 FANCM MTOR TBCK PLCE1	3.11e-05	180	219	7	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 ITGB4 ZBTB40 FANCM MTOR TBCK PLCE1	3.11e-05	180	219	7	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	ATP8A2 CNPY4 DHRS13 FBXL7 PCDH19 SNCAIP IRAG2	3.11e-05	180	219	7	886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 ITGB4 ZBTB40 FANCM MTOR TBCK PLCE1	3.11e-05	180	219	7	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP8B4 VWDE FAM221B BANP ZBTB40 CACNA2D1 FAM124B	3.34e-05	182	219	7	4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12
ToppCell	Endothelial-G\|World / shred on cell class and cell subclass (v4)	ATP8A2 NRXN2 APOBEC2 SELENOP SNCAIP CPNE7	3.44e-05	124	219	6	4b72809463f2986b7d1b7ab9de633ac4d7854a92
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	PLCXD2 MYRF WFS1 IQCN CAV1 RANBP17 PLCE1	3.46e-05	183	219	7	6821dca076318115d360ff426eb1218cfe104063
ToppCell	Control-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	TSPOAP1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1 DPP4	3.58e-05	184	219	7	c6affa0b12510363258f65e46bf2d47bf4a8e75f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC12A8 MYRF SH3RF1 WFS1 CAV1 RANBP17 PLCE1	3.71e-05	185	219	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 FBN2 FBXL7 GRM5 RIC8B MCTP2 PLCE1	3.71e-05	185	219	7	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	SLC12A8 MYRF CACNA2D1 SH3RF1 CAV1 RANBP17 PLCE1	3.71e-05	185	219	7	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF536 FBN2 FBXL7 GRM5 RIC8B MCTP2 PLCE1	3.71e-05	185	219	7	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	IPF-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	TSPOAP1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P CIITA ANKRD20A1	3.84e-05	186	219	7	962c2dada19185628ead77c32fcb07fa95114247
ToppCell	saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FBXW10B TRIP6 TBC1D9 TOR1B GCN1 TRMT44 ZNF830	3.97e-05	187	219	7	43ef900b76f3c38bd8ce9858201124130c743d56
ToppCell	saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FBXW10B TRIP6 TBC1D9 TOR1B GCN1 TRMT44 ZNF830	3.97e-05	187	219	7	6e5c38425b6b1d4774f8dcea7e146f1eab785c3e
ToppCell	IPF-Myeloid-cDC1\|IPF / Disease state, Lineage and Cell class	TSPOAP1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P CIITA ANKRD20A1	4.11e-05	188	219	7	2331a2bae1383820d598e93aa86c75b101069bac
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACER2 CYP2C18 IL20RB ITGB4 BMPER SNCAIP FAM124B	4.39e-05	190	219	7	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	DNAH14 ATP8A1 ATP2C2 SH3RF1 RANBP17 CEP70 PLCH1	4.69e-05	192	219	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	PLCXD2 ZFYVE9 MYRF WFS1 CAV1 RANBP17 PLCE1	4.69e-05	192	219	7	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	COPD-Myeloid-cDC1\|COPD / Disease state, Lineage and Cell class	TSPOAP1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P CIITA ANKRD20A1	4.69e-05	192	219	7	bd3d00b094d92463b06023361a71240851a542b8
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	DNAH14 ATP8A1 ATP2C2 SH3RF1 RANBP17 CEP70 PLCH1	4.69e-05	192	219	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	AK9 ULK4 DNAH6 DNAH10 DNAI2 PLCH1 CFAP69	4.85e-05	193	219	7	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF536 ATP8A1 RAB40B MYRF SELENOP SLC44A1 FAM222A	5.01e-05	194	219	7	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH6 SH3RF1 CAV1 DNAI2 PLCH1 CFAP69 MCTP2	5.35e-05	196	219	7	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH6 SH3RF1 CAV1 DNAI2 PLCH1 CFAP69 MCTP2	5.35e-05	196	219	7	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFB ATP8A1 MAP3K11 CASP10 CAV1 KANK3 FAM124B	5.52e-05	197	219	7	f4834378d5d31560b4efe5dee0d5b5d11caeb10f
ToppCell	Sigmoid-B_cell-B_cell_IgG_Plasma\|B_cell / Region, Cell class and subclass	ATP8A2 ASB8 CACNA2D1 COPB1 WFS1 GRM5 SLC44A1	5.70e-05	198	219	7	305d7ae9b070ac7211638a5282374c02bf13af40
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-7\|TCGA-Brain / Sample_Type by Project: Shred V9	ANKRD20A3P ANKRD20A8P RAD54L TRIM48 FANCM SUV39H2	5.77e-05	136	219	6	d94f0fbeb7b80d4cf0687d1924ebf8f9dd07358c
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH14 ATP8A1 ATP2C2 SH3RF1 RANBP17 CEP70 PLCH1	5.88e-05	199	219	7	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANKRD20A3P FAM221B DNAH6 DNAH10 RAB40A DNAI2 PLCE1	5.88e-05	199	219	7	92778939e9d06599c7d06cfd8f4362b97ed0606b
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH14 ATP8A1 ATP2C2 SH3RF1 RANBP17 CEP70 PLCH1	5.88e-05	199	219	7	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P1\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PDGFB SPOCD1 MYRF ALOX5 DNAH10 SLC44A1	6.01e-05	137	219	6	80f1a6cfb48ccfba1c3545fdcd5fcb3157272aca
ToppCell	10x5'-bone_marrow-Lymphocytic_B-Pro-B\|bone_marrow / Manually curated celltypes from each tissue	NRXN2 CIITA BMPER SH3RF1 WFS1 DOK4	1.15e-04	154	219	6	8a8c3851888ab86ca2b13ccc042cde1fef8d88f8
ToppCell	10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3\|Liver / Manually curated celltypes from each tissue	ABHD15 AK9 VWDE DNAH14 FAM124B CFAP69	1.56e-04	163	219	6	7f61483eeb1fde21843c6391468e13cb0cc2a89f
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Npnt_(Layer_5a)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LRTM1 INSM2 DNAH6 TAS1R1	1.65e-04	56	219	4	112a412816287423089c0333a42432a6ab4500dc
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 ATP8A2 XPO5 ULK4 POMC PRKDC	1.67e-04	165	219	6	475905d608fac628960188ae4a18010b8097417e
ToppCell	Mild-Myeloid-Mast\|Mild / Condition, Lineage, Cell class and cell subclass	ACER2 ATP8A2 CACNA2D1 RET EYS CEP70	1.67e-04	165	219	6	5fa9552c37890c5cc7e672a47038aebba2413cb4
ToppCell	Mild-Myeloid-Mast-\|Mild / Condition, Lineage, Cell class and cell subclass	ACER2 ATP8A2 CACNA2D1 RET EYS CEP70	1.67e-04	165	219	6	93d3909a0f5f43d473d5005c842d7d73e25eceed
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ACAP1 ATP8B4 MLC1 KANK3 MCTP2 CPNE7	1.78e-04	167	219	6	94642b3dae035fedb6e8b9745f440096a4539f3c
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	ACAP1 TSPOAP1 MALT1 CCDC28A-AS1 KANK3 CPNE7	1.78e-04	167	219	6	c0c944eae0514dc8e00d0c2892a0792e157695ec
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ACAP1 ATP8B4 MLC1 KANK3 MCTP2 CPNE7	1.78e-04	167	219	6	42b299273a6c72a625b204d55f4f3c4eebd6d185
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ACAP1 ATP8B4 MLC1 KANK3 MCTP2 CPNE7	1.78e-04	167	219	6	ecf5bc634e1e01efd783617eb81d1704e903ea21
ToppCell	Control\|World / group, cell type (main and fine annotations)	ATP2C2 SH3RF1 IQCN RANBP17 PLCH1 MUC5AC	1.84e-04	168	219	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	mild_COVID-19-HSPC\|mild_COVID-19 / disease group, cell group and cell class (v2)	VWDE CACNA1C SELENOP RANBP17 FAM124B CFAP69	1.84e-04	168	219	6	90b33962adb77d8326dee403712118398b4d1315
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RPL36A CIITA INSM2 DGKD USF3 APPL1	1.90e-04	169	219	6	c3a6179a64589a370108fea809b157839347759c
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM184B PDGFB DNAH6 UNC79 DNAH10 PLCH1	1.90e-04	169	219	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACER2 ITGB4 SPOCD1 ALOX5 MUC5AC PLCE1	2.03e-04	171	219	6	59b9dbaa05b6e5740edc633c9ce1181565550d5b
ToppCell	Control-Myeloid-Mast\|World / Disease state, Lineage and Cell class	ATP8B4 CACNA1H CACNA2D1 SLC44A1 DIP2C MCTP2	2.03e-04	171	219	6	ed8e61d524f4cddc6084b261175df54d2a64a60f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACER2 ITGB4 SPOCD1 ALOX5 MUC5AC PLCE1	2.03e-04	171	219	6	a5b9dd2b6a54db7962beeb5a9ceb9dacfb613fa7
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP8B4 LRRC69 SLC12A8 ANKRD20A4P POMC RANBP17	2.09e-04	172	219	6	028a5441242b2cc760cafc1822120180619c63ae
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP8B4 LRRC69 SLC12A8 ANKRD20A4P POMC RANBP17	2.09e-04	172	219	6	9fc70b1a143a8ec910336c23b761d908bb6aecb2
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP8B4 LRRC69 SLC12A8 ANKRD20A4P POMC RANBP17	2.09e-04	172	219	6	13d7117f92a92d77d6b4335ed800c585dc8b4511
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP8B4 LRRC69 SLC12A8 ANKRD20A4P POMC RANBP17	2.09e-04	172	219	6	3d83b2f03ad3af4dae3fe6cc0a0ef356872ca94f
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP8B4 LRRC69 SLC12A8 ANKRD20A4P POMC RANBP17	2.09e-04	172	219	6	a3d431aed12c1192e8dca1dc85b8340fb7354f8d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ATP8B4 ACO1 UNC79 WDR72 GRK6 RAB11FIP3	2.16e-04	173	219	6	8888434641ea554a9b62c436e87920378eef29cd
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM184B RPL36A PDGFB UNC79 DNAH10 PLCH1	2.16e-04	173	219	6	66f37c1437705734b20601656fa4aa1d92ca30be
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM184B RPL36A PDGFB UNC79 DNAH10 PLCH1	2.16e-04	173	219	6	649b08a409095592cccf31883be69c754411280d
ToppCell	PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ULK4 DNAH6 DNAH10 DNAI2 CFAP57 PLCH1	2.22e-04	174	219	6	f41d05a3703d7092bd3c4a97c15ae13069aaa4ad
ToppCell	10x3'2.3-week_17-19-Lymphocytic_T-T_NK-Treg\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FAM184B PDGFB ANKRD39 PLCXD2 DPP4 BCDIN3D	2.22e-04	174	219	6	7ca39c9ecd609e5ade30dac1a948a4a4fff1b3b2
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	ZFYVE9 MYRF SH3RF1 CAV1 RANBP17 PLCE1	2.22e-04	174	219	6	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	PND07-28-samps-Epithelial-Epithelial-non_alveolar\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ULK4 DNAH6 DNAH10 DNAI2 CFAP57 PLCH1	2.29e-04	175	219	6	c01a15b2084da4a18f8ff3623f44eb9dfe499f10
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	ELOA2 TSPOAP1 ATP8A2 CNPY4 LRTM1 TRIM66 ZFYVE9 ATP2C2 CASP10 DOK4 HNRNPUL2	2.73e-06	193	218	11	4431_UP
Drug	YF-1	CIITA NLRP8 CASP10 RELB NLRP9 NLRP14 NLRP4	1.50e-05	83	218	7	CID000445779
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; PC3; HT_HG-U133A	TRAF3IP1 PDGFB ITGB4 ADH6 ATP8A1 ALOX5 CASP10 SLC44A1 VPS41 ARHGEF2	1.96e-05	195	218	10	4634_UP
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	CNPY4 SLC12A8 TBC1D9 FBXL7 ATP8A1 DPP4 REXO5 PACS1 DIP2C RAB11FIP3	2.43e-05	200	218	10	3713_DN
Drug	Isradipine	CACNA1H CACNA1C CACNA2D1	2.95e-05	7	218	3	DB00270
Drug	Nifedipine	CACNA1H CACNA1C CACNA2D1	4.68e-05	8	218	3	DB01115
Drug	Nitrendipine	CACNA1H CACNA1C CACNA2D1	4.68e-05	8	218	3	DB01054
Drug	NDGA	PLCXD2 ATP2C2 ALOX5 CACNA2D1 COPB1 POMC RELB LTA4H PLCH1 PLCE1	4.68e-05	216	218	10	CID000004534
Drug	GTP[S]	PLCXD2 MALT1 AP1B1 MLC1 KCNJ4 CACNA1H RIC8A RAB40B CACNA1C CACNA2D1 COPB1 POMC RAB40A GRM5 HNRNPUL2 PLCH1 PLCE1	5.94e-05	591	218	17	CID000001764
Drug	L-648051	PHGDH ALOX5 LTA4H	6.97e-05	9	218	3	CID000122010
Drug	nimodipine	ATP2C2 CACNA1H CACNA1C CACNA2D1 POMC GRM5 SLC25A15 APPL1	8.05e-05	145	218	8	CID000004497
Drug	aa1-777	ALOX5 LTA4H	9.13e-05	2	218	2	CID000146153
Drug	ocobullenone	ALOX5 LTA4H	9.13e-05	2	218	2	CID000197600
Drug	15-HETE methyl ester	ALOX5 LTA4H	9.13e-05	2	218	2	CID006439200
Drug	BI-L-239	ALOX5 LTA4H	9.13e-05	2	218	2	CID006439222
Drug	BI-L-226	ALOX5 LTA4H	9.13e-05	2	218	2	CID006439221
Drug	ethylmalate	ALOX5 LTA4H	9.13e-05	2	218	2	CID000024197
Drug	belamcandol A	ALOX5 LTA4H	9.13e-05	2	218	2	CID005321906
Drug	EH-Hete	ALOX5 LTA4H	9.13e-05	2	218	2	CID006438576
Drug	oxoline	ALOX5 LTA4H	9.13e-05	2	218	2	CID000169137
Drug	Ardisianone A	ALOX5 LTA4H	9.13e-05	2	218	2	CID006443649
Drug	AC1L3R15	CACNA2D1 NLRP14	9.13e-05	2	218	2	CID000093857
Drug	BI-L-357	ALOX5 LTA4H	9.13e-05	2	218	2	CID006440014
Drug	L-670,630	ALOX5 LTA4H	9.13e-05	2	218	2	CID000124255
Drug	NSC314033	ALOX5 LTA4H	9.13e-05	2	218	2	CID000432739
Drug	L-689,065	ALOX5 LTA4H	9.13e-05	2	218	2	CID003083422
Drug	3-methyladamantane-1-carboxylic acid	ALOX5 LTA4H	9.13e-05	2	218	2	CID000286125
Drug	iridial	ALOX5 LTA4H	9.13e-05	2	218	2	CID000442422
Drug	CGS 21595	ALOX5 LTA4H	9.13e-05	2	218	2	CID000129437
Drug	Lagunamycin	ALOX5 LTA4H	9.13e-05	2	218	2	CID006444405
Drug	CGS 19213	ALOX5 LTA4H	9.13e-05	2	218	2	CID003082237
Drug	EP10161	ALOX5 LTA4H	9.13e-05	2	218	2	CID000130953
Drug	FR110302	ALOX5 LTA4H	9.13e-05	2	218	2	CID000164102
Drug	AC-5-1	ALOX5 LTA4H	9.13e-05	2	218	2	CID006449829
Drug	linoleic acid hydroxamate	ALOX5 LTA4H	9.13e-05	2	218	2	CID006449796
Drug	phytylplastoquinone	ALOX5 LTA4H	9.13e-05	2	218	2	CID006449782
Drug	AA-863	ALOX5 LTA4H	9.13e-05	2	218	2	CID000133543
Drug	tert-butyldimethylsilanol	ALOX5 LTA4H	9.13e-05	2	218	2	CID000554527
Drug	5-keto-(7E,9E,11Z,14Z)-eicosatetraenoic acid	ALOX5 LTA4H	9.13e-05	2	218	2	CID006438890
Drug	L-651896	ALOX5 LTA4H	9.13e-05	2	218	2	CID006438824
Drug	ETH647	ALOX5 LTA4H	9.13e-05	2	218	2	CID000195746
Drug	ICI216800	ALOX5 LTA4H	9.13e-05	2	218	2	CID000131453
Drug	santalene	ALOX5 LTA4H	9.13e-05	2	218	2	CID000094164
Drug	A-69412	ALOX5 LTA4H	9.13e-05	2	218	2	CID000130007
Drug	RHC 80267	PLCXD2 ALOX5 CACNA2D1 DGKD LTA4H PLCH1 PLCE1	1.04e-04	112	218	7	CID000005063
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; HL60; HT_HG-U133A	TBC1D9 ZFYVE9 DOK1 CASP10 CAV1 RET PTPA SLC44A1 CSE1L	1.24e-04	197	218	9	2205_DN
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	PDGFB ITGB4 FBXL7 CASP10 CSE1L DOK4 HNRNPUL2 PLCH1 CPNE7	1.24e-04	197	218	9	6271_UP
Drug	Heliotrine [303-33-3]; Down 200; 12.8uM; HL60; HT_HG-U133A	TRPC4AP PEX6 ZFYVE9 APOBEC2 ZBTB40 CASP10 RET FEM1B SLC44A1	1.24e-04	197	218	9	2180_DN
Drug	Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ELOA2 CNPY4 SLC12A8 ZFYVE9 APOBEC2 CACNA2D1 ARHGEF2 PLCH1 MUC5AC	1.29e-04	198	218	9	3342_UP
Drug	Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TRAF3IP1 FOCAD MALT1 FBXL7 CACNA1H DOK1 CSE1L DOK4 APPL1	1.29e-04	198	218	9	3313_DN
Drug	Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A	PDGFB PEX10 ZFYVE9 CACNA1H RELB FAAP100 SLC44A1 PLCH1 ZNF292	1.34e-04	199	218	9	6465_DN
Drug	Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; HL60; HT_HG-U133A	ELOA2 ATP8A2 ZIM2 ATP8A1 ZFYVE9 CIITA RANBP17 PLCH1 RAB11FIP3	1.34e-04	199	218	9	2187_UP
Drug	Felodipine	CACNA1H CACNA1C CACNA2D1	1.35e-04	11	218	3	DB01023
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; PC3; HT_HG-U133A	PDGFB SLC12A8 ZFYVE9 WEE1 GRK6 PACS1 PTPA MTOR TTC31	1.39e-04	200	218	9	6298_DN
Drug	azidopine	PHGDH TBC1D9 CACNA2D1 PTPA	1.40e-04	28	218	4	CID000656406
Disease	body weight	PDXDC1 PDGFB DNAH14 TRIM66 FBN2 ULK4 PRMT7 UNC79 HNRNPLL CACNA1C SH3RF1 COPB1 RTTN POMC CEP192 RET VIRMA BCDIN3D NBAS EYS USF3 MTOR LTBP3	3.14e-05	1261	208	23	EFO_0004338
Disease	sexual dimorphism measurement	PDXDC1 FAM184B ABHD15 TRPC4AP TSC2 MFGE8 MAP3K11 ULK4 HERC1 SPOCD1 GCN1 MYRF SELENOP DNAH10 MRGPRF POMC RELB ZMIZ1 PACS1 KANK3 LTBP3	3.99e-05	1106	208	21	EFO_0021796
Disease	leiomyoma (is_marker_for)	PDGFB TSC2 CAV1 CCNG1	4.30e-05	28	208	4	DOID:127 (is_marker_for)
Disease	ornithine translocase deficiency (implicated_via_orthology)	SLC25A2 SLC25A15	4.95e-05	2	208	2	DOID:0050720 (implicated_via_orthology)
Disease	amino acid metabolic disorder (is_implicated_in)	PHGDH SLC25A15 PCCB	5.46e-05	11	208	3	DOID:9252 (is_implicated_in)
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	PDXDC1 CYP2C18 PEX6 PEX10 BANP ALOX5 TRIM48 DNAH10 RELB ZMIZ1	1.02e-04	321	208	10	EFO_0004612, EFO_0004639
Disease	Nephrocalcinosis	SLC26A1 POMC	1.48e-04	3	208	2	C0027709
Disease	Growth abnormality	ZMIZ1 ZNF292	1.48e-04	3	208	2	C0262361
Disease	Focal Cortical Dysplasia of Taylor, Type IIb	TSC2 MTOR	1.48e-04	3	208	2	C1846389
Disease	FOCAL CORTICAL DYSPLASIA OF TAYLOR	TSC2 MTOR	1.48e-04	3	208	2	C1846385
Disease	Focal Cortical Dysplasia of Taylor, Type IIa	TSC2 MTOR	1.48e-04	3	208	2	C1846386
Disease	Isolated focal cortical dysplasia type II	TSC2 MTOR	1.48e-04	3	208	2	cv:C1846385
Disease	FOCAL CORTICAL DYSPLASIA, TYPE II	TSC2 MTOR	1.48e-04	3	208	2	607341
Disease	MAJOR AFFECTIVE DISORDER 2	DAO MLC1 PTPA	2.18e-04	17	208	3	C1839839
Disease	non-Hodgkin lymphoma (is_implicated_in)	MALT1 RAD54L CASP10	2.18e-04	17	208	3	DOID:0060060 (is_implicated_in)
Disease	diet measurement	PDXDC1 FAM184B ZNF536 IL20RB DNAH14 TRIM66 KCNJ4 CACNA1H SH3RF1 GRK6 GRM5 DIS3 RANBP17 NBAS PTPA RIC8B PRKDC PCCB	4.87e-04	1049	208	18	EFO_0008111
Disease	LYMPHOMA, NON-HODGKIN, FAMILIAL	RAD54L CASP10	4.88e-04	5	208	2	605027
Disease	response to platinum based chemotherapy, cytotoxicity measurement	EYS SNCAIP	4.88e-04	5	208	2	EFO_0004647, EFO_0006952
Disease	Lymphoma, non-Hodgkin, familial	RAD54L CASP10	4.88e-04	5	208	2	cv:C4721532
Disease	stem Cell Growth Factor-beta measurement	ATP8B4 RAB11FIP3	4.88e-04	5	208	2	EFO_0802090
Disease	Non-Hodgkin lymphoma	RAD54L CASP10	4.88e-04	5	208	2	cv:C0024305
Disease	platelet reactivity measurement, response to clopidogrel	CYP2C18 CCNG1 PLCE1	5.51e-04	23	208	3	EFO_0004985, GO_1903493
Disease	Sarcosine measurement	PEX6 PCDHGB2 PCDHGA3	5.51e-04	23	208	3	EFO_0021668
Disease	Immunologic Deficiency Syndromes	CACNA1C EPG5 NBAS	5.51e-04	23	208	3	C0021051
Disease	lipid measurement, high density lipoprotein cholesterol measurement	PDXDC1 CYP2C18 PEX10 MYRF ALOX5 TRIM48 DNAH10 RELB ZMIZ1	5.93e-04	330	208	9	EFO_0004529, EFO_0004612
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	PDXDC1 ZNF536 TSC2 ALOX5 POMC MTOR	6.56e-04	148	208	6	C0279702
Disease	Symptomatic Infantile Spasms	TSC2 POMC	7.28e-04	6	208	2	C0393699
Disease	Cryptogenic Infantile Spasms	TSC2 POMC	7.28e-04	6	208	2	C0393698
Disease	Hypsarrhythmia	TSC2 POMC	7.28e-04	6	208	2	C0684276
Disease	Salaam Seizures	TSC2 POMC	7.28e-04	6	208	2	C1527366
Disease	Nodding spasm	TSC2 POMC	7.28e-04	6	208	2	C0546878
Disease	spasmus nutans	TSC2 POMC	7.28e-04	6	208	2	C1527306
Disease	peroxisomal disease (implicated_via_orthology)	PEX6 PEX10	7.28e-04	6	208	2	DOID:906 (implicated_via_orthology)
Disease	Jackknife Seizures	TSC2 POMC	7.28e-04	6	208	2	C0553558
Disease	muscular atrophy (implicated_via_orthology)	RELB MTOR	1.01e-03	7	208	2	DOID:767 (implicated_via_orthology)
Disease	Abnormality of the skeletal system	ZMIZ1 ZNF292	1.35e-03	8	208	2	C4021790
Disease	1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) measurement	PEX6 MYRF	1.35e-03	8	208	2	EFO_0800392
Disease	peroxisomal biogenesis disorder (is_implicated_in)	PEX6 PEX10	1.35e-03	8	208	2	DOID:0080377 (is_implicated_in)
Disease	Intellectual Disability	ATP8A2 PEX6 AP1B1 NRXN2 ZBTB40 RTTN ZMIZ1 PACS1 MTOR ZNF292	1.35e-03	447	208	10	C3714756
Disease	triglycerides to phosphoglycerides ratio	PDXDC1 DNAH10 KANK3 PCCB	1.37e-03	68	208	4	EFO_0022327
Disease	Malignant neoplasm of breast	ACAP1 PHGDH MFGE8 MROH7 RIC8A SPOCD1 RAD54L NLRP8 CAV1 ZMIZ1 SUV39H2 EPG5 NLRP9 NLRP14 MTOR DIP2C APPL1	1.67e-03	1074	208	17	C0006142
Disease	level of Phosphatidylcholine (O-18:1_20:3) in blood serum	PDXDC1 MYRF	1.72e-03	9	208	2	OBA_2045130
Disease	1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) measurement	PDXDC1 MYRF	1.72e-03	9	208	2	EFO_0800271
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	PDXDC1 CYP2C18 MYRF ALOX5 TRIM48 DNAH10 ZMIZ1 PCCB	1.86e-03	315	208	8	EFO_0004574, EFO_0004612
Disease	free cholesterol to total lipids in large LDL percentage	PDXDC1 MYRF KANK3 PCCB	1.88e-03	74	208	4	EFO_0022280
Disease	Bipolar Disorder	DAO MFGE8 MLC1 ULK4 CACNA1C WFS1 POMC GRM5 PACS1 PTPA	2.18e-03	477	208	10	C0005586
Disease	Sarcomatoid Renal Cell Carcinoma	PDXDC1 ZNF536 ALOX5 POMC MTOR	2.18e-03	128	208	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	PDXDC1 ZNF536 ALOX5 POMC MTOR	2.18e-03	128	208	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	PDXDC1 ZNF536 ALOX5 POMC MTOR	2.18e-03	128	208	5	C1266044
Disease	Papillary Renal Cell Carcinoma	PDXDC1 ZNF536 ALOX5 POMC MTOR	2.18e-03	128	208	5	C1306837
Disease	Renal Cell Carcinoma	PDXDC1 ZNF536 ALOX5 POMC MTOR	2.18e-03	128	208	5	C0007134
Disease	Shortened QT interval	CACNA1C CACNA2D1	2.61e-03	11	208	2	C0151879
Disease	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	PEX6 PEX10	2.61e-03	11	208	2	C4721541
Disease	Autistic Disorder	DAO TSC2 NRXN2 CACNA1H CACNA1C POMC ZNF292	2.62e-03	261	208	7	C0004352
Disease	waist-hip ratio	IL20RB TRIM66 CIITA ANKRD28 DPP4 DNAH10 COPB1 CEP192 IQCN ZMIZ1 BCDIN3D RIC8B SLC44A1 LMX1A LTBP3 FAM124B PCCB PLCE1	2.77e-03	1226	208	18	EFO_0004343
Disease	Amelogenesis Imperfecta	ITGB4 LTBP3	3.12e-03	12	208	2	C0002452
Disease	level of Phosphatidylcholine (O-16:0_20:3) in blood serum	PDXDC1 MYRF	3.12e-03	12	208	2	OBA_2045115
Disease	triacylglycerol 56:6 measurement	PDXDC1 ATP2C2 MYRF	3.46e-03	43	208	3	EFO_0010433
Disease	Zellweger Spectrum	PEX6 PEX10	3.66e-03	13	208	2	C3658299
Disease	Infantile Severe Myoclonic Epilepsy	PCDH19 POMC	3.66e-03	13	208	2	C0751122
Disease	Zellweger-Like Syndrome	PEX6 PEX10	3.66e-03	13	208	2	C0751594
Disease	dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement	PDXDC1 MYRF	3.66e-03	13	208	2	EFO_0800547
Disease	Infantile Refsum Disease (disorder)	PEX6 PEX10	3.66e-03	13	208	2	C0282527
Disease	Thyroid carcinoma	TSC2 RET MTOR	3.70e-03	44	208	3	C0549473
Disease	Malignant neoplasm of salivary gland	ZIM2 ITGB4 MLC1	3.94e-03	45	208	3	C0220636
Disease	multiple myeloma, monoclonal gammopathy	PDGFB ULK4	4.26e-03	14	208	2	EFO_0000203, EFO_0001378
Disease	Kartagener syndrome (implicated_via_orthology)	AP1B1 DNAI2	4.26e-03	14	208	2	DOID:0050144 (implicated_via_orthology)
Disease	unipolar depression, information processing speed, cognitive function measurement	TSPOAP1 NLRP9 TBCK	4.46e-03	47	208	3	EFO_0003761, EFO_0004363, EFO_0008354
Disease	Salivary Gland Neoplasms	ZIM2 ITGB4 MLC1	4.46e-03	47	208	3	C0036095
Disease	Seizures	TSC2 FBXL4 POMC ZMIZ1 TBCK ZNF292	4.62e-03	218	208	6	C0036572
Disease	urate measurement, bone density	DNAH14 FBXL4 MLC1 DGKD CCNG1 RANBP17 EYS HEATR6 LATS2 CEP70 PRKDC	4.69e-03	619	208	11	EFO_0003923, EFO_0004531
Disease	cis/trans-18:2 fatty acid measurement, trans fatty acid measurement	MYRF CASP10	4.89e-03	15	208	2	EFO_0006821, EFO_0006824
Disease	Peroxisome biogenesis disorders	PEX6 PEX10	4.89e-03	15	208	2	C1832200
Disease	Adrenoleukodystrophy, Neonatal	PEX6 PEX10	4.89e-03	15	208	2	C0282525
Disease	Sinus Node Dysfunction (disorder)	CACNA2D1 POMC	4.89e-03	15	208	2	C0428908
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	PDXDC1 DNAH10 COPB1 RELB KANK3 PCCB	5.26e-03	224	208	6	EFO_0004574, EFO_0008317
Disease	Adenoid Cystic Carcinoma	ZIM2 ITGB4 MLC1 PRKDC	5.55e-03	100	208	4	C0010606
Disease	Neuralgia, Supraorbital	CACNA2D1 GRM5	5.56e-03	16	208	2	C0038870
Disease	Neuralgia	CACNA2D1 GRM5	5.56e-03	16	208	2	C0027796
Disease	Cardiovascular Abnormalities	ZMIZ1 ZNF292	5.56e-03	16	208	2	C0243050
Disease	Zellweger Syndrome	PEX6 PEX10	5.56e-03	16	208	2	C0043459
Disease	Neuralgia, Atypical	CACNA2D1 GRM5	5.56e-03	16	208	2	C0234247
Disease	Neuralgia, Stump	CACNA2D1 GRM5	5.56e-03	16	208	2	C0234249
Disease	Neuralgia, Iliohypogastric Nerve	CACNA2D1 GRM5	5.56e-03	16	208	2	C0423712
Disease	Neuralgia, Perineal	CACNA2D1 GRM5	5.56e-03	16	208	2	C0423711
Disease	Paroxysmal Nerve Pain	CACNA2D1 GRM5	5.56e-03	16	208	2	C0751373
Disease	Nerve Pain	CACNA2D1 GRM5	5.56e-03	16	208	2	C0751372
Disease	Neuralgia, Ilioinguinal	CACNA2D1 GRM5	5.56e-03	16	208	2	C0751371
Disease	Neuralgia, Vidian	CACNA2D1 GRM5	5.56e-03	16	208	2	C0042656
Disease	level of Phosphatidylcholine (18:0_20:3) in blood serum	PDXDC1 MYRF	5.56e-03	16	208	2	OBA_2045093
Disease	succinylcarnitine measurement	ZNF536 PTPA	5.56e-03	16	208	2	EFO_0020020
Disease	pancreatic cancer (is_marker_for)	ALOX5 ABCC5 RET MUC5AC	5.75e-03	101	208	4	DOID:1793 (is_marker_for)
Disease	Squamous cell carcinoma of the head and neck	TSC2 WEE1 TBCK	5.92e-03	52	208	3	C1168401
Disease	triglycerides to total lipids in very large VLDL percentage	PDXDC1 MAP3K11 MYRF	6.24e-03	53	208	3	EFO_0022340
Disease	esophageal carcinoma, gastric carcinoma	ATG2B EPG5	6.27e-03	17	208	2	EFO_0000178, EFO_0002916
Disease	Antibody Deficiency Syndrome	CACNA1C EPG5	6.27e-03	17	208	2	C0003257
Disease	alpha-L-iduronidase measurement	SLC26A1 RNF212	6.27e-03	17	208	2	EFO_0020139
Disease	cholesterol to total lipids in very large VLDL percentage	PDXDC1 MAP3K11 MYRF	6.58e-03	54	208	3	EFO_0022244
Disease	ceramide measurement	DHRS13 MYRF ZMIZ1 CCNG1 EYS SNCAIP	6.61e-03	235	208	6	EFO_0010222
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	PDXDC1 CYP2C18 ALOX5 TRIM48 DNAH10 ZMIZ1 PCCB	6.88e-03	312	208	7	EFO_0004612, EFO_0010351

Protein segments in the cluster

Peptide	Gene	Start	Entry
CQIDVCDKENRTPLI	ANKRD20A1	91	Q5TYW2
INCQDPSIKTICLRL	BANP	46	Q8N9N5
TQVVELDLKTVVPCC	ACO1	356	P21399
CNCKTVLPLAVERTS	C21orf62	61	Q9NYP8
LACPSKSLELRKCEA	FAM222A	16	Q5U5X8
PSDLCQLKECISVLF	EPG5	426	Q9HCE0
NPIVLEECKALVRCN	CDY1	486	Q9Y6F8
TERLPSKCEVCKLLS	CNPY4	31	Q8N129
IKPDSQTITCENCRL	ERVK-19	396	O71037
IKPDSQTITCENCRL	ERVK-8	396	Q902F8
KPDSQTITCENCRLL	ERVK-9	396	Q9UKH3
CQIDICDKENRTPLI	ANKRD20A8P	91	Q5CZ79
VPCTALLIAELKRCD	ACER2	156	Q5QJU3
IDAVAPLEKVCLISC	ADH6	161	P28332
PTLCRAVCQLSEALL	CIITA	611	P33076
CQIDVCDKENRTPLI	ANKRD20A4P	91	Q4UJ75
LLCCDIDPVLVKRAE	BCDIN3D	106	Q7Z5W3
TAKEALICPTCNVTI	ARHGEF2	61	Q92974
ITNTCLDRELIPSLC	DEPDC4	276	Q8N2C3
RKLLRPSTESCCVAQ	CCDC28A-AS1	6	A0A096LPI5
CAPNKDVADCLALIL	ANKRD28	966	O15084
REEKAACLRNICLPS	AKAP11	826	Q9UKA4
DLRLCTVKLCPDSER	ACAP1	311	Q15027
CTDLELSLKCRAPEV	AP1B1	921	Q10567
ICCRVTPLQKAQVVE	ATP8B4	786	Q8TF62
DRKARLACDLLPCNS	ANKRD39	161	Q53RE8
CAPNKDVADCLALIL	ANKRD52	1001	Q8NB46
QCDPTLSLKVCDEAL	DNAI2	441	Q9GZS0
VPCIKSFLIEIQCIS	CAV1	131	Q03135
ELTKLVPPECNCLRE	ATP2C2	161	O75185
KLNPVCCELDISIVD	ATG2B	676	Q96BY7
VICCRVSPLQKSEVV	ATP8A1	771	Q9Y2Q0
VICCRVSPLQKSEIV	ATP8A2	791	Q9NTI2
SPCAACADRIIKTLS	APOBEC2	126	Q9Y235
SLVCKPSALAQCLLR	ABHD15	71	Q6UXT9
ENPIIKSCPECRVIS	MKRN2	281	Q9H000
RQLILCKPSCDVRDL	MROH7	801	Q68CQ1
CKPSCDVRDLLDLLL	MROH7	806	Q68CQ1
ELIDSPECLSKCQLL	RANBP17	36	Q9H2T7
PECLSKCQLLLEQGT	RANBP17	41	Q9H2T7
GLPRCCNEKIELAIL	RANBP17	536	Q9H2T7
PSKVLSLQDLCCRTI	RAB40A	186	Q8WXH6
PSKVLSLQDLCCRAV	RAB40B	186	Q12829
PSKVLSLQDLCCRTI	RAB40AL	186	P0C0E4
VKIEQVVCCRLTPLQ	RAD54L	406	Q92698
LASCLSPKCLEISIE	TSPOAP1	1486	O95153
SELRSCTPCLKANIE	RAB11FIP3	556	O75154
SELRICRINKESGPC	RELB	301	Q01201
VSLDAKCQPCLLTRT	IQCN	251	Q9H0B3
VPLCVTEETFTKLCN	HNRNPLL	461	Q8WVV9
EGCCRLEPTLKNARI	DAO	261	P14920
PCCSARELQESKITV	KCNJ4	346	P48050
IKCVEDVSLCNPERT	KIAA1107	626	Q9UPP5
KVCPELCNLTQLTTL	LRRC69	51	Q6ZNQ3
CRAILPCQDTPSVKL	LTA4H	141	P09960
AVSRNPLCTLCLEER	PEX10	266	O60683
CQIDVCDKENRTPLI	ANKRD20A2P	91	Q5SQ80
LEQESRCQPKVCGLR	CCNG1	21	P51959
RCQPKVCGLRLIESA	CCNG1	26	P51959
DSIPLCRKCETRVLA	FBXW10B	21	O95170
ARDPQLCEKLTVLCS	ASB8	231	Q9H765
KIDRDLLCRQSPKCI	PCDH19	86	Q8TAB3
LLCRQSPKCIISLEV	PCDH19	91	Q8TAB3
CVTSALCIPLASQKR	RAB3GAP2	131	Q9H2M9
VECAIQTCPELLRKD	MMADHC	146	Q9H3L0
PTLIREKSCGACLRE	ELOA2	246	Q8IYF1
PERTNELLQIIGKCC	TRAF3IP1	101	Q8TDR0
VIVLLQVVCSCPDKC	LRTM1	11	Q9HBL6
IIRSVCSEPCEKGQI	GRM5	506	P41594
SDLCVCPLADLSERK	MCTP2	476	Q6DN12
DVNLCLDKTCLSIVP	EYS	1656	Q5T1H1
CAPSLLVALDICSKN	MFGE8	16	Q08431
CLDLEQCSLKVLEPE	MALT1	71	Q9UDY8
SPEARDLITKLCCSA	LATS2	941	Q9NRM7
VILLCEALKNPDCTL	NLRP8	941	Q86W28
SLLLEALSCPDCVVQ	MMS19	916	Q96T76
TPLDQCKVLIPTTRC	FYCO1	1411	Q9BQS8
ATCIRKPLIATCSLD	CFAP57	396	Q96MR6
LVTCDCLKLIDPQTQ	APPL1	546	Q9UKG1
CSILETQDPCLKLDE	FAM184B	526	Q9ULE4
VIKEPCVLLTECQFT	FANCM	916	Q8IYD8
KQLCCVPLTLEDLEE	HERC1	4606	Q15751
QIDICSLPRKICCTE	DEFB114	46	Q30KQ6
TVKAPDIECVLRCSV	FEM1B	401	Q9UK73
DLQCLCVKTTSQVRP	PF4V1	41	P10720
LACKCETVAAARPVT	PDGFB	176	P01127
PKSVCEGCQRVILDR	LMX1A	31	Q8TE12
DREQICGKQPLCVLD	PCDHGB2	91	Q9Y5G2
DQLVACIESKLPVLC	PDXDC1	476	Q6P996
CIESKLPVLCCTLQL	PDXDC1	481	Q6P996
KLEPSVSLVNVLDCC	PEX6	891	Q13608
PSISNKRIVGCICEE	COX5B	81	P10606
DRISLCLKVLSECSP	COPB1	611	P53618
RIISDISVPCKVSQC	FAM221B	281	A6H8Z2
DCCVKVAVRIRPQLS	KIF21B	6	O75037
DRALLPHVLCKNCVV	HNRNPUL2	396	Q1KMD3
KLTVNLDCLRVGCAP	NRXN2	791	Q9P2S2
SNLLECIRACKPDLS	POMC	41	P01189
LCISIVVLPKEDSCS	HEATR6	656	Q6AI08
NAACEILLAEKTCPS	MEIKIN	236	A0A087WXM9
KVTCLSCELNPERCQ	DPP4	441	P27487
VLLCALQSPCASVRE	GCN1	1086	Q92616
LLDTSPKRLETKCCD	NALF2	346	O75949
KELALVNCHLSPIDC	NLRP4	726	Q96MN2
CETVNVCRDITRLPK	MUC5AC	1671	P98088
INCSLCLKPDLLDFT	NPEPPSL1	61	A6NEC2
LCCRNLAVEKAVSEL	CYHR1	121	Q6ZMK1
IVLRLECVEPNCRSK	RPL36AL	66	Q969Q0
RLSVENVPCIVTLCK	EXOSC7	191	Q15024
CCVILKALVTSRSAP	FAAP100	251	Q0VG06
SRTPLGEFICQLCKE	INSM2	256	Q96T92
RLCTENLLKPDTREC	ITGB4	826	P16144
RLCPDRISLIKECIS	NBAS	1236	A2RRP1
RISLIKECISQSPTC	NBAS	1241	A2RRP1
IKPDSQTITCENCRL	ERVK-7	1156	P63135
PQKLISCRREEVDAC	IL20RB	281	Q6UXL0
ELLQDQRKPVVCTCS	PACS1	581	Q6VY07
LCEAICPAQAITIEA	NDUFS8	116	O00217
CCDLDVLASKKVQRP	PCCB	516	P05166
DREELCAQIPLCLVK	PCDHGA3	91	Q9Y5H0
SVLNSCCLRPDLAIL	ABCC5	656	O15440
CQIDVCDKENRTPLI	ANKRD20A3P	91	Q5VUR7
TDDNCIVLKTLPCLV	ARMC8	271	Q8IUR7
IPQVDISKVTTLCCL	DNAH6	1951	Q9C0G6
RTLDQLLDCICPEVR	FAM124B	26	Q9H5Z6
ATLELCVCILVRQLP	HEATR5A	1681	Q86XA9
REKCPVLSRDCALAI	BMPER	81	Q8N8U9
CLTLKNPIRRACISI	CACNA1C	106	Q13936
DCKVIRLAECVSVAP	DOK1	61	Q99704
CKRVPHTVLDRQLLC	CEP70	201	Q8NHQ1
KPDSQTITCENCRLL	ERVK-24	286	P61566
IKPDSQTITCENCRL	ERVK-25	396	P61570
IKPDSQTITCENCRL	ERVK-6	396	Q69384
KPDSQTITCENCRLL	ERVK-7	286	P61567
RTVLKPDSVCLCVSD	PRMT7	396	Q9NVM4
KGTCPCDTRLLIQAE	CACNA2D1	1021	P54289
TLPDLCRLAQTCKLL	FBXL4	296	Q9UKA2
KVLTRRLCQDTPNVC	FBXL7	171	Q9UJT9
TIAQCCPELRRLEVS	FBXL7	206	Q9UJT9
SLCSCEETRPLKCLV	CPNE7	291	Q9UBL6
CRSIKLQCELYPSRE	DIP2C	1161	Q9Y2E4
LLQKCPTDLSCVIRN	ADGRF2	186	Q8IZF7
VDICVLNPKCVTLSE	DNAH14	1471	Q0VDD8
KPDSQTITCENCRLL	ERVK-21	396	P61565
RTQCIADKPEEKSLC	LTBP3	391	Q9NS15
RNPRITSLCLLKDCE	CEP192	911	Q8TEP8
TVITPCRKLILCADN	DGKD	116	Q16760
SCPLLVCRSTEKCEL	DND1	126	Q8IYX4
TNCLKLLESLTPLCE	IRAG2	251	Q12912
CELSPRLREACVALQ	KANK3	546	Q6NY19
NLTCLEDLCKTVVPK	CASP10	166	Q92851
ALCVAACPRQELKTL	SLC44A1	111	Q8WWI5
CLVEELRKTNASPCD	CYP2C18	151	P33260
SLEACARCAVKPVEL	CCDC177	96	Q9NQR7
ARSDCRKPLSTNEIC	CST8	91	O60676
IKPDSQTITCENCRL	HERVK_113	396	Q902F9
RTPTKQACIDIDECI	FBN2	566	P35556
ARSLCSQLLCKDPAE	GRK6	416	P43250
SEDSCCLRLHKVLEP	CACNA1H	1246	O95180
PSSELRIQICKCIVD	CFAP69	151	A5D8W1
VIKRCCEAPNRLSDL	DNAH10	1526	Q8IVF4
QCIAQEKVIPALACL	SLC12A8	336	A0AV02
QVCLSIEACTIRLPA	C18orf63	151	Q68DL7
VCLRGCPKVTEISNV	DOK4	51	Q8TEW6
IIALKAVCLEEPNLC	MAP3K11	176	Q16584
CDIVPCLQVKDLIQT	FOCAD	226	Q5VW36
CLKACAPSRVVVVAS	DHRS13	156	Q6UX07
LSVLCCNLPEAKRRI	ORC3	341	Q9UBD5
PAKSTLVESRCCRDL	MTOR	351	P42345
VVECLVQPCLTLLRK	RTTN	891	Q86VV8
VQPCLTLLRKVLCGD	RTTN	896	Q86VV8
CIDKLCITPQELLSR	AK9	1621	Q5TCS8
VDEDCLRIPSTKRVC	TRMT44	486	Q8IYL2
DIPILTQCFECIKTI	TRIM48	61	Q8IWZ4
CALQLETCPLCRKEI	RSPRY1	551	Q96DX4
CDCSPDITLKIQFLR	TRPC4AP	446	Q8TEL6
VIRGSQAELKCPVCL	RNF181	66	Q9P0P0
CNPVLIRRCTELPEK	ALOX5	241	P09917
TDLCICINSSAKPIV	MRGPRF	276	Q96AM1
ISVGPCLKQCVRDTV	PLCE1	436	Q9P212
IVLRLECVEPNCRSK	RPL36A	66	P83881
KDIPTTCQVSCLEVL	RIC8B	56	Q9NVN3
SKLRVILPALSCCSN	PRAMEF22	366	A3QJZ6
VICQDQSKTVLLLPC	RNF26	381	Q9BY78
KTIPELCRRCDTQNE	SNCAIP	26	Q9Y6H5
ALVLCPTELVKCRLQ	SLC25A15	121	Q9Y619
ESLKCLCNLVLSSPV	RIC8A	116	Q9NPQ8
PELLSSNLCSLKCDV	DIS3	541	Q9Y2L1
ALALCPTELVKCRLQ	SLC25A2	121	Q9BXI2
CINQLLCKLPTDSEL	SELENOP	281	P49908
ECPVCLERLDASAKV	SH3RF1	11	Q7Z6J0
EQLRELCCAVATAPK	C10orf82	51	Q8WW14
KLECLGLQTCPITRA	NLRP9	886	Q7RTR0
ECLICKAPCRTVLLS	RNF212	41	Q495C1
VKLGSCPEDQLRCLS	WFDC5	76	Q8TCV5
IEDILSVLKCPNLCS	VWDE	881	Q8N2E2
LEKCATCSQPILDRI	TRIP6	336	Q15654
LRQKLIFSPCSDCEE	WEE1	21	P30291
AICLSIRITCKANPA	CSE1L	621	P55060
KCYVILCRPDLNSTE	TAS1R1	811	Q7RTX1
CSVLCVRALVQDLLP	SLC26A1	41	Q9H2B4
NKLCPACSVESLTLR	PLCXD2	186	Q0VAA5
KQSVSCDECIPLPRA	PTPA	86	Q15257
CIKVQRPVTELTLDC	REXO5	571	Q96IC2
VSLCDILDDSCPRKL	SPOCD1	121	Q6ZMY3
CLVSLDTLQELCRKE	SUV39H2	16	Q9H5I1
KVLLSICSLLTDCNP	UBE2E3	161	Q969T4
CFTSKEENLCSLIIP	TBC1D9	336	Q6ZT07
ICKTISCLLPDDLEV	ZNF292	371	O60281
SCLLPDDLEVKRACQ	ZNF292	376	O60281
CCDDSQLVKSVLPIA	WDR72	606	Q3MJ13
ICVPCGLRLAEKTQV	XPO5	46	Q9HAV4
QPRATATTLILCCLL	RAET1G	221	Q6H3X3
ACPLNSVRDVSKLDC	USF3	811	Q68DE3
LLRERKPVSCSTVLC	TBCK	81	Q8TEA7
CADLTLPEDISQLCK	TBCK	296	Q8TEA7
ACIATSCESRDPRKL	PSME4	1426	Q14997
THCPLEKALEICQQR	VPS41	636	P49754
EIIGLPVDCCKDQTR	PLCH1	766	Q4KWH8
ERQCLPSLDLSCKQL	PRKDC	1496	P78527
PLSCAVSKRRLECEE	RET	516	P07949
KPSVQCANLCERVRI	ZIM2	391	Q9NZV7
RLPLDKITECLSELC	TNPO3	571	Q9Y5L0
CLNLVPPLKSSCIER	ZNF536	491	O15090
TQPCETCSSLLKDIL	ZNF547	86	Q8IVP9
LSCALCNTPVKSELL	ZNF830	51	Q96NB3
DPVRQCAECALVSLK	ZFYVE21	91	Q9BQ24
SLLELEDRLQCPICL	TRIM73	6	Q86UV7
LRKVLISDSLDPCCR	PHGDH	6	O43175
ISDSLDPCCRKILQD	PHGDH	11	O43175
KVIVLSGLCSNDCPR	ITFG1	441	Q8TB96
LQCSALLPREKELAC	TRIM66	361	O15016
EILPNLVCCSAKNLR	CCT8	141	P50990
CVQLCDLASPTALLI	VIRMA	1181	Q69YN4
KSLLESCPINCQLLE	ZFC3H1	1626	O60293
SEIVILLQCLPDEKC	ZFYVE9	976	O95405
CPVCNKTALLEGLEV	ZMIZ1	781	Q9ULJ6
CCREERPLNASALKL	TOR1B	56	O14657
VTLCRTINVKELCEP	TSC2	241	P49815
TEKRVILNCCEGRTP	ZBTB40	386	Q9NUA8
ILNCCEGRTPKETIE	ZBTB40	391	Q9NUA8
AILCTDKCKRPEITN	ULK4	31	Q96C45
IKLDCSLRPSCPLEV	TTC31	11	Q49AM3
CVLPLKCSLDSSLRI	UNC79	2186	Q9P2D8
IASKDCIPCSELAVI	WFS1	421	O76024
ECPSKCLVEVLIAIS	MLC1	251	Q15049
PECKLQTLRLESCNL	NLRP14	756	Q86W24
SVVLCSLRSKEEPCE	MYRF	1071	Q9Y2G1